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Abstract: Background: Sitting time has negative effects on health, increasing the risk of obesity,
osteoporosis, diabetes, and cancer. Thus, primary health care education interventions aimed to
reduce sitting time and sedentary behavior could have beneficial effects on people’s health and well-
being. The purpose of this study was to assess the effectiveness of an intervention based on reducing
sitting time to decrease cardiometabolic risk on a sample of women diagnosed with fibromyal-
gia and moderate obesity. Methods: Randomized controlled trial to evaluate the effectiveness of
an intervention to decrease cardiometabolic risk in 84 participants. Sedentary behavior was moni-
tored using an accelerometer before and at 3-month follow-up. Results: Compared with the control
group, body mass index decreased, and the number of steps taken increased, in the intervention
group 3 months after the intervention. No significant differences were found in the rest of the
variables measured. Conclusion: The intervention group decreased sitting time after the intervention.
Group activities and support from primary care may be useful to improve treatment adherence. RCT
registration: NCT01729936.
Keywords: sitting time; sedentary behavior; fibromyalgia; obesity
1. Introduction
Fibromyalgia (FM) is a chronic disorder characterized by chronic widespread mus-
culoskeletal pain [1] and accompanied by fatigue, cognitive disturbances, psychiatric,
and multiple somatic symptoms [2]. FM has an unknown etiology and uncertain patho-
physiology. As suggested by ongoing research, FM is considered to be a pain regulation
disorder and often classifies as a form of central sensitization syndrome [3]. Due to the
nature of its symptoms, as well as its chronic nature, patients diagnosed with FM tend
to engage in sedentary behavior (SB) [4]. SB occurs when “the energy expended is less
than or equal to 1.5 metabolic equivalents (MET), keeping the posture of sitting or lying
down” [5]. SB is considered one of the major public health problems and it is a risk factor
for the development of noncommunicable diseases [6] including obesity [7], diabetes [8],
certain types of cancer [9], and sleep disturbances [10]. According to van der Ploeg [11] and
Pines [12], SB shortens life expectancy and increases the risk of mortality independently
of physical activity. However, according to other authors [13], the risk of death associated
with prolonged sitting time (ST) can be reduced by moderate physical activity for 60 to
75 min a day.
Int. J. Environ. Res. Public Health 2021, 18, 6237. https://doi.org/10.3390/ijerph18126237 https://www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2021, 18, 6237 2 of 11
There is no curative treatment for FM. Symptom management strategies include
pharmacological and nonpharmacological treatments aimed at alleviating pain, increas-
ing restorative sleep, improving physical function, and, ultimately, improving quality of
life [14]. As demonstrated by previous research, physical activities including aerobic exer-
cise [15], strength exercises [16], pool activities [17], and daily steps [18] have a beneficial
effect on people with FM. Specifically, physical activity can reduce the perception of pain
and depression, and can improve the quality of sleep and self-management in patients
with FM [18,19]. However, despite the evidence, women with FM tend to spend less time
engaging in moderate and high intensity physical activity [20].
Previous studies on SB in different population groups, namely office workers [21],
patients with chronic conditions [22], and even children [23], have found an association
between reduced SB and positive health outcomes. In the population of patients with FM,
a positive correlation has been established between reduced SB and impact of the disease
on quality of life [19], pain, and fatigue [24]. However, as outlined above, patients with
FM are significantly less active than sedentary healthy controls. Whereas ST seems to be
consistently associated with symptoms of FM [25], there is insufficient evidence about
the effects of reducing ST on health outcomes of people with FM who are overweight or
moderately obese.
In Spain, people with FM are frequently managed in the community by primary care
nurses and physicians [26,27]. Primary healthcare providers are responsible for imple-
menting health promotion programs, which can have a significant impact on patients’
lifestyle [28]. To our knowledge, there are no previous studies on health promotion inter-
ventions aimed at reducing ST in patients with FM in our context. Our initial hypothesis
was that reducing sitting time through a primary care health education intervention would
reduce cardiometabolic risk in women with FM who were overweight or moderately obese.
Therefore, the aim of this study was to evaluate the impact of a primary care health educa-
tion intervention to reduce ST on cardiometabolic risk in a sample of patients diagnosed
with FM and who were overweight or moderately obese.
2. Materials and Methods
2.1. Design
We present the results from a randomized controlled trial to reduce daily hours of ST
in overweight and obese women with FM.
2.2. Participants
The participants were recruited from two primary care centers in the city of Zaragoza
(Spain) from September 2013 to September 2014. A total of 494 women who had a diag-
nosis of FM and were moderately obese or overweight were contacted via telephone by
a researcher and qualified nurse (B.R.-R.), who explained the purpose of the investigation
and invited them to take part in the study. If they accepted, they were given an appointment
with the same researcher at their primary care center, where the selection criteria were
carefully reviewed, the aim and procedures of the investigation were clearly explained, the
consent form was signed (if applicable), and the participants were given an accelerometer
with the aim of assessing and recording SB.
The inclusion criteria to participate in this study were: (1) being female, (2) having
a formal diagnosis of FM, (3) being 25–65 years old, (4) having a body mass index (BMI) of
25–34.9 kg/m2, and (5) spending more than 6 h a day sitting, as measured by the Marshall
Sitting Questionnaire (MSQ) in its Spanish version [29]. We excluded individuals with
contraindications to regular physical activity including osteoarticular diseases, advanced
heart disease, severe walking difficulties, cancer on treatment, individuals who were not
able to communicate in Spanish, and those who had an unstable demographic situation.
Our rejection rate was high, with 282 women refusing to take part in the study. In
addition, 88 women could not be contacted (a researcher gave them a phone call three
times at different times and there was no reply) and 37 were excluded due to not meeting
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the selection criteria. A final sample of 84 participants was recruited to participate in the
study; 46 were randomized to the intervention group and 38 to the control group following
a single-blind randomization method. Unfortunately, only 31 women in the intervention
group and 21 in the control group, and 19 in the intervention group and 15 in the control
group attended the first and second post-intervention assessments, respectively. Figure 1
shows a flowchart of the recruitment process and RCT design; Figure 2 shows a timeline of
the study procedures.
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Figure 2. Timeline of study procedures.
2.3. Description of the Intervention
The patients wore the accelerometer constantly for a week before the second appoint-
ment. A week after the initial meeting, the participants attended a second, face-to-face
ap ointme t ith the sam researcher (B.R.-R.). During this second appointment, the
participants wer giv n the opportunity to ask questions, pretest measurements were
taken, th acceleromet r was rem ved, nd the participants w re randomized to either
the intervention or the control group. Patients randomized to the intervention group
received a 6 month health education intervention consisting of five face-to-face or tele-
phone appointments, depending on the patient’s preference. The appointments lasted an
average of 30 min, and all the patients in the intervention group who completed the process
(n = 19) attended the five appointments (nonattendance was a reason for exclusion). During
these appointments, the researcher and the participants jointly identified opportunities to
decrease ST and planned activities in order to decrease SB, namely using the stairs, getting
off the bus one stop earlier, standing up and walking after finishing a book chapter, etc.
An effort was made to help the patients integrate these activities into their daily routine.
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The participants assigned to the control group were encouraged to continue with their
daily activities as usual.
The same parameters were measured in the intervention and the control group.
2.4. Data Collection
Data were collected during a personal interview before the intervention, immediately
after the intervention, and at 3-month follow-up.
The following information was collected by a research nurse through face-to-face
interviews with the participants at the beginning of the study. The participants completed
a questionnaire of sociodemographic and clinical variables designed ad hoc, including age,
marital status, employment status, and educational level. The clinical and anthropometric
variables were measured thrice by the same research nurse at the beginning of the study,
after the intervention, and at 3-month follow-up. We used a Seca 770 scale to measure
weight and height and calculate BMI. The abdominal perimeter and tricipital fold were
measured using the same tape measure. Blood pressure was also measured thrice using
the same electronic sphygmomanometer; measurements were taken three times and the
average values were calculated in order to obtain the final measure.
Biochemical variables, triglycerides, total cholesterol, HDL, LDL, and glucose were
measured through a blood test performed at the primary care center.
The MSQ in its Spanish version [29] was used to measure the total number of hours of
ST (sedentary behavior) prior to recruitment. This questionnaire comprises 20 items that
assess time spent sitting (hours and minutes) on weekdays and weekends in five domains:
(a) while travelling to and from places (e.g., work, shops); (b) while at work; (c) while
watching television; (d) while using a computer at home; and (e) at leisure, not including
watching television (e.g., visiting friends, movies, eating out). ST was considered prolonged
if it was over 6 h a day; thus, patients whose ST was less or equal to 6 h a day were excluded
(n = 37) from this study according the criterion established by Martinez-Ramos et al. [30].
We used a 3M accelerometer developed by PAL Technologies Ltd. in order to measure
energy expenditure, hours spent sitting and lying down, changes in position, and number
of steps taken. The participants were instructed to wear the activPAL™ (PAL Technologies
Ltd., Glasgow, UK) on their thigh for 7 consecutive days. They were asked to remove it
only during aquatic activities. When the patient’s activPAL™ was removed (7 days later),
the data were downloaded all at once. All the records comprising measurements taken
through a period of at least 6 days were considered valid and included in the analyses.
The activPAL™ was programmed and used by the participants in both groups throughout
two one-week periods: (1) before the intervention, and (2) 3 months after the intervention.
2.5. Data Analysis
As per protocol analysis [30], descriptive statistics was used to describe the sample
using frequency, percentage, mean, and standard deviation (SD) as appropriate. We
analyzed the association between categorical variables using a chi-square test. The Shapiro–
Wilk test was used to test for normality of the data. The Kruskal–Wallis test was applied
for statistical comparison of quantitative variables that followed a normal distribution,
and the ANOVA test was used for those that followed a normal distribution. In order
to estimate the effect of the health education program to reduce ST, the results from the
pretest and the posttest measures were compared using the nonparametric Wilcoxon test
and Friedman test for related means. The Epidat 4.2 program was used to calculate the
sample size. Taking 494 people as the total population diagnosed with FM registered at the
two primary care centers where the study was carried out, and assuming that the Spanish
average BMI is 28.6 in this population, with a standard deviation of 5.1 [31], a maximum
error of 3%, and a confidence interval of 95%, we would need a population of 84 people.
Drop-out analyses were calculated; the response rate was 17% and the completion rate
was 40% [32,33].
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Data codification, processing, and analysis were completed using the statistical soft-
ware Statistical Package for the Social Science (SPSS version 22 for Windows, IBM Corp.,
Chicago, IL, USA), accepting a level of significance of p < 0.05.
2.6. Ethical Considerations
This study was reviewed and approved by the Clinical Research Ethics Committee
of Aragón (C.P-C.I. PI12/00121) prior to the start of this investigation. The investigation
adhered to the principles outlined in the Declaration of Helsinki [34]. All the participants
included in the study were informed about the study aims and procedures and gave their
informed consent to participate.
3. Results
The mean age of our participants was 55 years. Over a third of the participants in
both groups were employed. Three quarters of the women in the control group, and just
over 60% of the women in the intervention group, were married. Only a minority of our
participants were educated to university degree level. No significant differences were
found between the women in the intervention group and those in the control group, except
for their level of education. The participants’ perception of ST (hours) throughout the day
was 6.15 (SD 3.46), as measured by the MSQ (Table 1).
Table 2 presents the intergroup differences between participants’ anthropometric,
clinical, and biochemical variables, and activPAL™ values before and after the intervention
and at 3-month follow-up. We found no statistically significant differences between the
intervention and the control groups at baseline, with the exception of BMI (p = 0.017),
tricipital fold (p < 0.001), triglycerides (p = 0.053), and glycemia values (p = 0.006). There
were no significant differences in any of the variables recorded by activPAL™, and the
average time spent sitting was 10.08 (SD 2.79) hours per day. There were no significant
differences between the groups immediately after the intervention, with the exception
of changes in the position (p = 0.029). At 3-month follow-up, we observed a significant
reduction in ST in the intervention group compared with the control group (p = 0.048).
No other significant differences between groups were found at this stage. The Friedman
test was used to compare the dependent variables measured at the beginning and at the
end of the study between groups (interaction p-value). We found that the patients in the
intervention group increased the number of steps taken (p = 0.000) and had a lower BMI
(p = 0.000) by the end of the study (Table 2).
Table 1. Sociodemographic characteristics between the groups at baseline.
KERRYPNX Control Group (n = 38) Intervention Group (n = 46) Total (n = 84) p Value
Age (mean (SD)) 57.42 (5.80) 54.21 (8.44) 55.48 (7.6) 0.472 a
Employment
status Freq (%) Freq (%) Freq (%)
0.501 b
Housewife 3 (7.9%) 8 (17.4%) 11 (12.5%)
Unemployed 7 (18.4%) 8 (17.4%) 15 (17%)
Unemployed due
to disability 6 (15.8%) 8 (17.4%) 14 (15.9%)
Employed 15 (39.5%) 16 (34.8%) 31 (35.2)
Retired 6 (15.8%) 4 (8.7%) 10 (11.4%)
No answer 1 (2.6%) 2 (4.3%) 1 (1.1%)
Marital status Freq (%) Freq (%) Freq (%)
0.206 b
Single 2 (5.3%) 5 (10.9%) 7 (8%)
Married 29 (76.3%) 29 (63%) 58 (65.9%)
Widowed 0 3 (6.5) 3 (3.4%)
Divorced 4 (10.5%) 8 (17.4) 12 (13.6%)
No answer 3 (7.9%) 1 (2.2%) 4 (4.5%)
Level of education Freq (%) Freq (%) Freq (%)
<0.001 b
University 1 (2.6%) 4 (8.7%) 5 (6%)
Low/medium
studies 33 (86.8%) 39 (84.7%) 72 (85.8%)
No answer 4 (10.5%) 3 (6.5%) 7 (8.3%)
Marshall
Questionnaire 6.15 (3.46) 6.3 (4.3) 6.15 (3.46) 0.169
a
a ANOVA; b Chi-square test.
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Table 2. Intergroup differences in anthropometric, clinical, and biochemical variables and activPAL™ values before and after the intervention and at 3-month follow-up.
Pretest Posttest 3-Month Follow Up
CG (n = 38) IG (n = 46) p a CG (n = 21) IG (n = 31) p a CG (n = 15) IG (n = 19) p a p b
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
BMI (kg/m2) 28.67 (2.67) 30.13 (2.8) 0.017 29.04 (3.31) 30.0 (3.31) 0.138 29.67 (2.93) 29.21 (3.55) 0.108 0.000
Abdominal perimeter (cm) 102.75 (9.27) 103.03 (8.87) 0.887 100.4 (7.2) 104.6 (9.2) 0.151 96.5 (20.1) 102.4 (11) 0.493 0.687
Tricipital fold (cm) 33.95 (5.20) 28.51 (4.71) <0.001 32.9 (5.9) 30.5 (5.08) 0.099 39.13 (17.7) 29.5 (5.3) 0.207 0.688
Systolic blood pressure (mmHg) 126.95 (16.11) 124.09 (14.56) 0.396 127.26 (13.8) 120.5 (10.5) 0.429 115.8 (16) 119 (14.9) 0.300 0.890
Diastolic blood pressure (mmHg) 78.82 (11.23) 79.50 (9.72) 0.766 77.94 (10.2) 72.6 (8.7) 0.073 80.8 (12.6) 72.2 (10.1) 0.058 0.417
Cholesterol (mg/dL) 215.58 (35.25) 219.67 (35.98) 0.602 230 (44.4) 233 (35.3) 0.877 209.7 (50.7) 208.5 (56.8) 0.816 0.444
HDL (mg/dL) 59.76 (13.38) 61.50 (11.89) 0.532 66 (22.9) 56.5 (6.3) 0.295 73.7 (29.3) 208.5 (56.8) 0.245 0.646
LDL (mg/dL) 128.81 (32.69) 137.07 (34.41) 0.270 133 (32.3) 153.1 (34.8) 0.429 111.6 (53.3) 116 (73.7) 0.611 0.761
Triglycerides (mg/dL) 142.32 (59.39) 119.72 (46.22) 0.053 160.5 (65.4) 142.1 (73.8) 0.433 124.7 (35.4) 125.75 (24.67) 0.054 0.161
Glycemia (mg/dL) 96.18 (15.66) 88.2 (10.04) 0.006 97.1 (18.7) 92.3 (9.3) 0.162 96.5 (23.9) 93.5 (12.9) 0.531 0.584
METs 37.5 (7.6) 36.1 (3.3) 0.522 35.31 (2.27) 35.88 (3.49) 0.400 35.50 (2.53) 36.05 (3.12) 0.062 0.483
Steps 8373.1 (2820.5) 9492.16 (5857.2) 0.309 9059 (3731.6) 8053.4 (3428.5) 0.187 8161.35 (3155.74) 9539.46 (5822.31) 0.675 0.000
Sitting time (hours) 10.08 (2.7) 10.9 (2.4) 0.157 10.9 (2.5) 10.7 (2.8) 0.243 10.50 (2.84) 10.31 (2.42) 0.048 0.413
Change position 46.49 (13.88) 49.14 (14.77) 0.424 46.19 (9.80) 42.67 (12.86) 0.029 47.25 (14.25) 48.56 (15.24) 0.587 0.891
a Kruskal–Wallis test; b Friedman test: interaction p-value (group x time); CG: Control group; IG: Intervention group.
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Intragroup differences in the control and intervention group at baseline and at
3-month follow-up are shown in Table 3. In the control group, significant differences
were observed in BMI (p < 0.001) and MET (p = 0.021) values before and 3 months after the
intervention. We found a significant decrease in the intervention group’s BMI (p < 0.001)
and diastolic blood pressure (p = 0.018) 3 months after the intervention.
Table 3. Intragroup differences in the intervention and the control group at baseline and 3-month follow-up.
Baseline CG 3-MonthFollow-Up CG p
a Baseline IG 3-MonthFollow-Up IG p
a
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
BMI (kg/m2) 28.67 (2.67) 29.67 (2.93) 0.001 30.13 (2.8) 29.21 (3.55) <0.001
Abdominal Perimeter (cm) 102.75 (9.27) 96.5 (20.1) 0.865 103.03 (8.87) 102.4 (11) 0.618
Tricipital Fold (cm) 33.95 (5.20) 39.13 (17.7) 0.124 28.51 (4.71) 29.5 (5.3) 0.913
Systolic Blood Pressure (mmHg) 126.95 (16.11) 115.8 (16) 0.184 124.09 (14.56) 119 (14.9) 0.968
Diastolic Blood Pressure (mmHg) 78.82 (11.23) 80.8 (12.6) 0.421 79.50 (9.72) 72.2 (10.1) 0.018
Cholesterol (mg/dL) 215.58 (35.25) 209.7 (50.7) 0.672 219.67 (35.98) 208.5 (56.8) 1.000
HDL (mg/dL) 59.76 (13.38) 73.7 (29.3) 0.248 61.50 (11.89) 208.5 (56.8) 0.197
LDL (mg/dL) 128.81 (32.69) 111.6 (53.3) 0.398 137.07 (34.41) 116 (73.7) 0.655
Triglycerides (mg/dL) 142.32 (59.39) 124.7 (35.4) 0.063 119.72 (46.22) 125.75 (24.67) 0.109
Glycemia (mg/dL) 96.18 (15.66) 96.5 (23.9) 0.735 88.2 (10.04) 93.5 (12.9) 0.713
METs 37.5 (7.6) 35.50 (2.53) 0.021 36.1 (3.3) 36.05 (3.12) 0.158
Steps 8373.1 (2820.5) 8161.35 (3155.74) 0.903 9492.16 (5857.2) 9539.46 (5822.31) 0.969
Sitting Time (hours) 10.08 (2.7) 10.50 (2.84) 0.382 10.9 (2.4) 10.31 (2.42) 0.084
Change Position 46.49 (13.88) 47.25 (14.25) 0.230 49.14 (14.77) 48.56 (15.24) 0.887
a Wilcoxon test; CG: Control group, IG: Intervention group.
4. Discussion
This RCT evaluated the impact of a primary care health education intervention to
reduce ST on cardiometabolic risk in a sample of patients diagnosed with FM and who
were overweight or moderately obese. With regard to the sociodemographic characteristics
of our sample, we found that only a minority of our participants had university level
studies. At 3-month follow-up, sitting time and diastolic blood pressure decreased in the
intervention group compared to the control group. In addition, by the end of the study,
the women in the intervention group increased the number of steps taken and reduced
their BMI.
ST in our population was similar to that observed in patients with rheumatic diseases
and was longer than ST in the general adult population [5,35]. This is not surprising, as
people with FM do experiment similar symptoms to patients with rheumatic conditions,
including pain and fatigue [36,37].
The results from the MSQ were similar in both groups after randomization, indi-
cating that all of our participants had a similar perception of their SB. We compared
the results from the MSQ and the objective measurement of ST by means of the activ-
PAL™ and observed a significant difference between perceived and real ST. This implies
that our participants underestimated their ST daily [24,38]. This is in agreement with
previous studies [38,39] in a similar population, which suggest that ST values increase
when measured objectively through accelerometers, as opposed to subjectively through
self-administered questionnaires.
Surprisingly, daily ST was reduced slightly in the control group 6 months after recruit-
ment. This may have been due to the Hawthorne effect [40], whereby knowledge of the
purpose of the study may have encouraged the participants in the control group to reduce
their ST and increase their daily physical activity. Nevertheless, this reduction in ST in the
control group was short-lived as it was not maintained at 3-month follow-up. In contrast,
a significant reduction in ST was observed in the intervention group at 3-month follow-up.
However, our participants’ SB after the intervention was still prolonged. This may be due
to a number of reasons, including the nature of the intervention itself. Specifically, the
participants did not wear an accelerometer during the intervention period and, therefore,
they had no means to objectively evaluate their SB. It is possible that routinely using an
objective measurement of physical activity such as the activPAL™ may contribute to raise
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awareness of SB in this population and, thus, help patients to gradually increase their level
of physical activity and decrease ST. Another possible explanation for the limited impact
of the intervention on the participants’ SB is their actual willingness to make changes
to their daily habits. We did not take into account the participants’ pre-disposition to
make changes. It is likely that, despite agreeing to take part in our study, some of our
participants were not ready to change or, as proposed by Prochaska and Diclemente [41],
were in a precontemplative stage. We recommend that the participants’ readiness to change
is assessed prior to engaging in activities involving a change in daily habits, as it may have
an impact on the effectiveness of the intervention.
A slight decrease in BMI and in diastolic blood pressure was observed in the interven-
tion group at 3-month follow-up. However, the impact of the intervention on modifiable
cardiometabolic risk factors was not as large as expected. Patients with FM may find it
hard to maintain an adequate level of physical activity due to symptoms such as general
fatigue and widespread pain. In fact, there is an association between tiredness and inability
to perform the activities of daily living in our population [4]. This may result in an increase
in BMI [2] and the development of comorbidities including obesity [42], anxiety, and de-
pression [43] in this population. In view of our results, we suggest that interventions of
this kind are complemented with other activities which contribute to the reduction of SB.
For example, patients with FM could be integrated in regular group activities led by an
interdisciplinary healthcare team. Group activities can be an effective method to motivate
patients whilst establishing social relationships that could improve their mood and disease
management [44,45].
We recommend that interventions aimed at decreasing ST in the population of adults
with FM are individualized and tailored to the needs and characteristics of each patient,
are supervised by a health professional regularly, and, if possible, are complemented with
group activities in order to increase patient motivation and social support [46]. Future
studies in this area should analyze whether regularly and objectively measuring physical
activity in this population, by means of an accelerometer, improves the patients’ response
and adherence to interventions aimed at reducing SB.
Limitations
Modifying daily habits is not an easy task [47–49]. Although most of our patients
alleged medical reasons for abandoning the study, a lack of personal motivation may have
contributed to our dropout rate at 3 months after the end of the intervention. Thus, the
results must be interpreted with caution. A larger sample size and the introduction of
motivational strategies may result in a greater degree of adherence to the intervention
and may provide more conclusive results. Future studies in this field should specifically
address and measure treatment adherence during the intervention period. In addition,
it may be desirable to include a more comprehensive and extended follow-up period
in future research in this field. In addition, we wish to draw attention to the fact that
men were excluded from this RCT and, thus, their response to the intervention may be
different. Finally, data collection took place in 2013–2014. Although it is unlikely that
health promotion interventions in primary care in Spain have changed significantly since
then, the data are not recent.
5. Conclusions
The impact of a health promotion intervention to decrease ST in the population of
women with FM and moderate obesity was very limited. The results show a need for
more experimental studies aimed at reducing ST in the population of patients with FM.
However, we recommend that future interventions are tailored to the patients’ needs and
characteristics, are supervised regularly by a healthcare professional, and integrate group
activities with the aim of increasing motivation, and professional and social support.
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